News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
145–180
Matches
791
Sources here
19
Companies here
16
Search results Stored financial headlines

Active search

791 matching headlines

Ticker or company: ATRMain company stories
Clear

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

AtriCure Inc (ATRC) Stock News Today

This article provides the latest stock news for AtriCure Inc (ATRC), detailing its current stock price, market capitalization, and performance metrics. It also highlights that more news, earnings, analyst ratings, and key developments will be available soon.

ATRC main company
Sharemaestro market context Trend signal started 52 weeks +17.6% ATRC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Patriot National Bancorp Inc (PNBK) Stock News Today

This article provides current stock news for Patriot National Bancorp Inc (PNBK). It highlights the company's stock price, market capitalization, P/E ratio, and mentions that more news, earnings, and analyst ratings are expected soon. The page serves as a hub for financial information regarding …

PNBK main company
Sharemaestro market context Price below Trend Line 52 weeks -36.0% · Next-week setup negative 39.5% PNBK stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Patria (PAX) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Friday, July 31, 2026 at 9:00 a.m. ET CALL PARTICIPANTS Investor Relations Director - Andre MedinaChief Executive Officer - Alexandre Teixeira de Assumpção SaighChief Financial Officer - Raphael Denadai TAKEAWAYS Total Fundraising -- $2.3 billion in the second …

P2AX34 main company PAX main company
Sharemaestro market context Price below Trend Line 52 weeks -16.4% · Next-week setup negative 37.0% P2AX34 stored weekly price path from 22 Aug 2025 to 14 Aug 2026

AtriCure (ATRC) director Maggie Yuen reports sale of 3,500 shares

AtriCure director Maggie Yuen sold 3,500 shares of Common Stock on August 5, 2026, at a weighted average price of $38.42 per share, totaling approximately $134,470. The shares were sold in multiple trades ranging from $38.37 to $38.43, and she now directly holds 14,015 …

ATRC main company
Sharemaestro market context Trend signal started 52 weeks +17.6% ATRC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

AtriCure Inc (ATRC) Director Karen Prange Sells 3,564 Shares

AtriCure Inc (ATRC) Director Karen Prange sold 3,564 shares of the company on August 5, 2026, for a total value of approximately $138,283. This sale contributes to a pattern of 14 insider sells and no buys over the past year. The stock is currently …

ATRC main company
Sharemaestro market context Trend signal started 52 weeks +17.6% ATRC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Pulmatrix Inc (PULM) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Pulmatrix Inc (PULM), noting that no earnings forecast score is currently available for the company. It mentions the Biotechnology & Medical Research industry average score and includes a section on analyst ratings, though no specific ratings are …

PULM main company
Sharemaestro market context Price below Trend Line 52 weeks -68.5% · Next-week setup negative 44.7% PULM stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Patrick Industries Inc (PATK) Stock News Today

This page on TradingKey provides current stock news for Patrick Industries Inc (PATK), a company listed under Homebuilding & Construction Supplies. The page shows the latest stock price, market cap, P/E ratio, and notes that more news and analysis, financials, stock scores, technical forecasts, …

PATK main company
Sharemaestro market context Price below Trend Line 52 weeks -24.6% · Next-week setup positive 56.1% PATK stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Dynatrace, Inc. Stock 12‑Month Price Target Raised to $58.69, Implies 15% Upside

The average 12-month price target for Dynatrace, Inc. (DT) stock has increased to $58.69, up from $57.38, according to 32 analysts. This new target suggests a potential upside of approximately 15% from its August 5 closing price. The consensus rating among 39 covering analysts …

DT main company
Sharemaestro market context Trend signal active 52 weeks -0.5% · Next-week setup positive 58.7% DT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Director At AtriCure Sells $134K Of Stock

AtriCure Director Maggie Yuen sold 3,500 shares of the company's stock for a total of $134,470, as reported in an SEC filing on August 7. The company's shares were trading up 2.89% at $39.49 following the report. AtriCure demonstrated strong revenue growth of 12.83% …

ATRC main company
Sharemaestro market context Trend signal started 52 weeks +17.6% ATRC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Viatris’ high-range grind stands out in a generic-drug group short on Trend Signals

VTRS finished the week at $17.56, just 2.8% below its 52-week high, with an active 49-week trend backdrop but only baseline volume confirmation.

VTRS main company
Sharemaestro market context Trend signal active 52 weeks +56.5% VTRS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

AtriCure director Maggie Yuen sells $134,470 in stock

AtriCure Director Maggie Yuen sold 3,500 shares of the company's common stock for $134,470 on August 5, 2026. This transaction leaves Yuen with 14,015 shares. The sale occurred while AtriCure's stock is trading near its 52-week high, despite the company recently surpassing Q2 2026 …

ATRC main company
Sharemaestro market context Trend signal started 52 weeks +17.6% ATRC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

AtriCure, Inc. (ATRC) director sells 3,564 shares at $38.80

AtriCure, Inc. director Karen Prange sold 3,564 shares of common stock at $38.80 per share on August 5, 2026, in an open market or private transaction. Following this sale, Prange directly holds 22,809 shares of AtriCure. The transaction was reported in a Form 4 …

ATRC main company
Sharemaestro market context Trend signal started 52 weeks +17.6% ATRC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

AtriCure, Inc. (NASDAQ:ATRC) Receives Average Rating of "Moderate Buy" from Analysts

AtriCure, Inc. (NASDAQ:ATRC) has received a "Moderate Buy" consensus rating from analysts, with an average 12-month price target of $48.50. The company recently reported strong quarterly results, exceeding EPS and revenue estimates, and provided positive fiscal year 2026 guidance. While institutional ownership is high …

ATRC main company
Sharemaestro market context Trend signal started 52 weeks +17.6% ATRC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Viatris Earnings: Good Performance in Key Regions and Outlook Increase Make for a Solid Quarter

Viatris reported a strong second quarter with 5% revenue growth and 11% adjusted earnings per share growth, both surpassing FactSet consensus estimates. The company also raised its EPS guidance by 5% at the midpoint, despite shares trading down 3% post-announcement. This performance highlights solid …

VTRS main company
Sharemaestro market context Trend signal active 52 weeks +56.5% VTRS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

An AtriCure Director Sold $905,000 in Stock. Here's How to Read It

Key Points Karen Prange disposed of 3,564 shares for a total transaction value of approximately $138,283 on August 5. The sale resulted in a 14% reduction in the director's total direct equity holdings in the company. All transacted shares were held directly; the director …

ATRC main company
Sharemaestro market context Trend signal started 52 weeks +17.6% ATRC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Harrow Enters Agreement to Acquire Tyrvaya Dry Eye Treatment From Viatris Inc.

Harrow has entered into a definitive agreement to acquire Tyrvaya (varenicline solution), a dry eye nasal spray treatment, from Viatris Inc. This acquisition aims to expand Harrow's dry eye portfolio, complementing its Vevye franchise by offering a differentiated treatment option with a distinct mechanism …

VTRS main company
Sharemaestro market context Trend signal active 52 weeks +56.5% VTRS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Viatris Inc (VTRS) (Q2 2026) Earnings Call Highlights: Strong Growth and Raised Guidance Amid ...

Viatris Inc (VTRS) reported strong Q2 2026 results with $3.8 billion in revenues, a 3.5% operational growth year-over-year, and raised its full-year guidance. Key drivers included robust performance in Greater China and advancements in its R&D pipeline. The company also highlighted challenges such as …

VTRS main company VIA main company
Sharemaestro market context Trend signal active 52 weeks +56.5% VTRS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

AptarGroup Inc (ATR) Segment President Marc Prieur Sells 3,500 S

Marc Prieur, Segment President of AptarGroup Inc (ATR), sold 3,500 shares of the company on August 4, 2026, totaling approximately $476,910. This sale contributes to a pattern of insider selling over the past year, with 12 insider sells and no buys. Despite the insider …

ATR main company
Sharemaestro market context Price above Trend Line 52 weeks -5.5% ATR stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Patriot National Bancorp (PNBK) Projected to Announce Earnings on Thursday

Patriot National Bancorp (PNBK) is expected to report its Q2 2026 earnings before market open on Thursday, August 13th, with analysts projecting $0.25 per share on $8.40 million in revenue. The previous quarter saw the bank miss earnings expectations but exceed revenue estimates, leading …

PNBK main company
Sharemaestro market context Price below Trend Line 52 weeks -36.0% · Next-week setup negative 39.5% PNBK stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Viatris Inc. Stock 12‑Month Price Target Raised to $18.71, Implies 6% Upside

Viatris Inc. (VTRS) has seen its average 12-month price target raised from $18.14 to $18.71 by 7 analysts, suggesting a 6% potential upside from its August 5th closing price. The consensus analyst rating remains a "Buy," with 5 out of 12 analysts recommending a …

VTRS main company
Sharemaestro market context Trend signal active 52 weeks +56.5% VTRS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Viatris Inc (VTRS) Shares Fall 7.6% -- GF Value Says Still Overvalued

Viatris Inc (VTRS) shares fell 7.6% to $16.29, which is still 47.7% above its GF Value of $11.03, indicating the stock is significantly overvalued. The company has a GF Score of 58/100, with weak growth potential, and recent insider selling further suggests a cautious …

VTRS main company
Sharemaestro market context Trend signal active 52 weeks +56.5% VTRS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Viatris Inc. stock falls Thursday, underperforms market

Viatris Inc. (VTRS) stock fell 7.71% to $16.29 on Thursday, marking its second consecutive day of losses. This decline occurred during a broader market downturn, with the S&P 500 Index and Dow Jones Industrial Average also experiencing losses.

VTRS main company
Sharemaestro market context Trend signal active 52 weeks +56.5% VTRS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

ATRenew plans next financial update before U.S. markets open

ATRenew (NYSE:RERE) is scheduled to release its unaudited second quarter 2026 financial results before the U.S. market opens on Thursday, August 20, 2026. Management will host an earnings conference call at 08:00 A.M. Eastern Time (08:00 P.M. Beijing Time) on the same day to …

RERE main company
Sharemaestro market context Price below Trend Line 52 weeks +2.2% RERE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context